Today on Insight, John and Josh Rosenstern discuss the drug epidemic in the United States, as the Biden Administration is recommending that the Drug Enforcement Administration loosen federal restrictions on marijuana. They want a revision from a schedule one to a schedule three substance, after a review by the FDA. LSD and heroin are schedule one drugs, as schedule three drugs are said to have little chance of addiction. The problem with marijuana is that it does impair behavior, which should not be overlooked, and it is commonly a gateway drug that leads to other drug use or at least the experimentation of other substances and other social groups that may contribute to other dangers.
Up Next in 2023
-
Insight - Aug. 30th, 2023
Today on Insight, John and Josh Rosenstern discuss the Presidents of Turkey and Russia planning to meet in Russia to discuss the Black Sea grain deal. The UN and Turkey arranged the deal last summer, with Russia leaving the arrangement most recently. The deal helped with the exports of certain ...
-
Insight - Aug. 29th, 2023
Today on Insight, Josh Rosenstern discusses the Inflation Reduction Act under the Biden Administration that addresses more funding for climate change and the Medicare program provisions. As of March of this year, 66-million people in the US are enrolled in Medicare, with 51-million in Part-D, wh...
-
Insight - Aug. 28th, 2023
Today on Insight, John and Josh Rosenstern discuss protests and a great uproar in Libya following a meeting in Rome between the Foreign Ministers of Libya and Israel. Libyan leaders found the meeting to be inappropriate, as Libya’s own government is divided from the West to East. The sects with...
